UnitedHealth (UNH) Stock Lower Ahead of Q2 Earnings
Bloomberg News
NEW YORK (TheStreet) -- Shares of UnitedHealth Group (UNH) - Get Report are down 1.14% to $139.72 in midday trading Monday ahead of the company's 2016 second quarter results, due out before Tuesday's market open.
Analysts are modeling an increase year-over-year in earnings per share and revenue.
Wall Street is expecting the Hopkins, MN-based healthcare company to report earnings of $1.89 per share on revenue of $45.05 billion.
Last year, UnitedHealth earned $1.64 per diluted share on revenue of $36.26 billion.
Bernstein recently initiated coverage of the stock with an "outperform" rating and $171 price target.
The firm expects UnitedHealth's 2017 earnings per share to be above expectations, driven by strong margins, the Fly reported.
Bernstein said the company is projected to benefit from the strength of its Medicare, Medicaid and services businesses.
Separately, TheStreet Ratings Team has a "Buy" rating with a score of A+ on the stock.
The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share, increase in net income, solid stock price performance and good cash flow from operations.
Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
You can view the full analysis from the report here: UNH